Abstract:
A three-step differentiation protocol for generating spinal cord oligodendrocytes from human embryonic stem cells without foreign gene transfer is provided to prepare cell therapy compositions for treating spinal cord disease and spinal cord injury. A method for generating spinal cord oligodendrocytes from human embryonic stem cells comprises the following steps of: cultivating the human embryonic stem cells in a culture medium containing Sonic Hedgehog(Shh), Retinoic acid(RA) and noggin to prepare embryoid wherein ventral part spinal nerve ectoderm is increased in a first step; cultivating the embryoid in a culture medium containing basic fibroblast growth factor(bFGF) and platelet-derived growth factor(PDGF) in order to induce growth of precursor cell for the spinal cord oligodendrocytes in a second step; and cultivating the precursor cell in a culture medium containing cyclic adenosine monophosphate(cAMP), insulin-like growth factor 1(IGF-1) and neurotrophin 3(NT-3) to induce differentiation of the spinal cord oligodendrocytes in a third step.
Abstract:
본 발명은 인간배아 줄기세포로부터 배아체가 형성되는 과정에서 혈청, 액티빈 (activin A) 및 레티노산 (retinoic acid)을 순차적으로 처리하여 췌장내배엽이 증가된 배아체를 유도하고, 이를 췌장으로 분화 가능한 췌장전구세포로 분화를 촉진시키는 방법에 관한 것이다. 본 발명에 따르면, 이미 어느 정도 분화가 진행된 성체줄기세포와는 달리 배아줄기세포는 여러 단계의 분화과정을 거쳐 기능성 체세포로 분화가 되며, 각 단계에서 원치 않는 세포로 분화될 가능성이 있으므로, 초기 내배엽으로의 효과적인 단계별 분화촉진 및 이에 뒤따르는 췌장세포로 분화시킬 수 있다. 또한, 배아줄기세포로부터 내배엽으로의 분화를 우선적으로 촉진시킨 뒤, 췌장세포로의 분화를 유도할 경우 기존의 분화유도방법보다 췌장세포로의 분화수율을 증가시켜 대량의 췌장베타세포를 획득할 수 있다. 인간배아 줄기세포, 췌장전구세포, 혈청, 액티빈, 레티노산, 췌장 내배엽, 배아체, 췌장베타세포
Abstract:
A method for inducing differentiation of stem cells is provided to reduce the costs for differentiation by using inexpensive lithium chloride as a differentiation-inducing agent, induce the differentiation phenomenon similar as a normal development process in vitro culture, and increase differentiation efficiency. A method for inducing differentiation of stem cells comprises the steps of: (a) forming embryoid bodies from the stem cells through floating aggregation culture method; and (b) adding 5-20 mM of lithium chloride to the embryoid bodies and culturing them in a culture vessel containing an extracellular substrate such as laminin, collagen or Engelbreth-Holm-Swarm. Further, liver cell separating medicine is added into the embryoid bodies.
Abstract:
Methods for inducing differentiation from human embryonic stem cells to dopaminergic neurons are provided to block possibility of differentiation into various cells including myocardial cells, muscle cells, liver cells and hematopoietic cells, so that differentiation efficiency into high purity nerve cells for cell therapy is increased. A method for inducing differentiation from human embryonic stem cells to dopaminergic neurons comprises the steps of: treating embryoid bodies formed from human embryonic stem cells with 40-60 ng/ml of a vascular endothelial growth factor(VEGF) for 7-9 days to induce the neuroectoderm-increased embryoid bodies; culturing the neuroectoderm-increased embryoid bodies attached to a tissue culture dish to induce neural precursor cells; detaching the induced neural precursor cells from the tissue culture dish and re-attaching and culturing them in the dish to increase purity and maintain density uniformly; and finally differentiating the high purity of neural precursor cells to dopaminergic neurons. Further, a 20-30 ug/ml of fibronectin is added into the neuroectoderm-increased embryoid bodies.
Abstract:
본 발명은 인간 배아줄기세포를 소닉 헷조그(Sonic Hedgehog, Shh), 레티놀 산(Retinoic acid, RA), 노긴(noggin) 및 비트로넥틴(vitronectin)을 포함하는 배지에서 배양하여 복측 척수신경계세포가 증가된 배상체를 유도하는 것을 특징으로 하는 인간 배아줄기세포로부터 척수 희소돌기 아교세포로의 분화유도 방법에 관한 것이다. 본 발명에 따르면, 인간배아줄기세포를 정상 발생과정과 매우 유사한 후성학적인 세포분화의 최적 환경을 단계별로 조성하여 외부 유전자의 인위적 도입과정 없이 인간배아 줄기세포로부터 희소돌기 아교세포를 효과적으로 분화유도 할 수 있다. 또한 상기 분화 유도된 희소돌기 아교세포 또는 그 전구세포를 이용하여 척수질환 및 척수 손상 치료용 세포치료제 조성물을 개발할 수 있다.
Abstract:
A method for pre-treating a substrate using an electrostatic self-assembly process with nano diamond particles and a method for depositing a diamond thin film using the same. A surface of a nano diamond particle is coated with a polymer having an opposite polarity with respect to an electrostatic charge on the surface of the nano diamond particle. A surface of a substrate is treated with a polymer having an opposite polarity with respect to an electrostatic discharge on the substrate. The surface-treated substrate is immersed into a solution in which the coated nano diamond particles are dispersed. The nano diamond particle is deposited on the substrate through an electrostatic self-assembly process, so that it is used as a deposition core during a diamond thin film deposition. The polymer is selected from a group consisting of PSS(Poly Sodium 4-styrenen sulfonate), poly S-119, polyaniline, nafion, and PDDA(Poly DiallylDimethyl Ammonium chloride).